Canada House Cannabis Group Inc
CNSX:CHV
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
Canada House Cannabis Group Inc
CNSX:CHV
|
25.4m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
954.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
546.2B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
269.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
217.7B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
265.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.6B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
93.9B EUR |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Canada House Cannabis Group Inc
Glance View
Canada House Wellness Group, Inc. is an integrated medical cannabis company. The company is headquartered in Pickering, Ontario. The company went IPO on 2000-06-27. The firm's operated subsidiaries are: Canada House Clinics, Knalysis Technologies Inc and Abba Medix Corp. Its Canada House Clinics is focused on treating complex health issues through assessments, ongoing support, and data-driven treatment plans that are monitored by cannabinoid therapy educators. Its Knalysis Technologies, is a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Its Abba Medix Corp is engaged in producing cannabis genetics and products in a fully integrated seed-to-sale vertical and links the growth operations, patient services, and offers artificial intelligence (AI) assisted data reporting solutions.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Canada House Cannabis Group Inc is -3%, which is above its 3-year median of -9%.
Over the last 3 years, Canada House Cannabis Group Inc’s Net Margin has increased from -179.3% to -3%. During this period, it reached a low of -179.3% on Mar 30, 2020 and a high of -3% on May 30, 2023.